IDSA has published its first set of guidelines for the management of encephalitis.

A panel of IDSA members identifies and critiques important new infectious diseases studies in the current literature that have a significant impact on the practice of infectious diseases medicine.

New recommendations and discussion from the June meeting of the federal Advisory Committee on Immunization Practices (ACIP), according to IDSA’s ACIP liaison, Samuel Katz, MD, FIDSA.

Recommendations include vaccinating all children ages 5-18 years and targeting children aged 6 months through 4 years. Live, attenuated influenza vaccine is now approved for children as young as 2 years old.

The Emerging Infections Network discusses obtaining clofazimine to treat Mycobacterium avium-intracellulare (MAI) disease, and some limitations.

IDSA offers two e-mail services to help members stay informed of updates from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA).

Congress enacted legislation this month that stops steep Medicare physician payment cuts from taking effect this year.

Current 2009 budget proposals for federal infectious diseases programs give modest increases to the Centers for Disease Control and Prevention (CDC) and the National Institute for Allergy and Infectious Diseases (NIAID).

Personal and employer antiviral stockpiles, home doxycycline stockpiles, and more IDSA advocacy.

The online IDSA/Society for Healthcare Epidemiology of America (SHEA) Infection Control Fellows Course was designed to give infectious diseases fellows and others basic training and background in infection control.

Many opportunities to receive continuing medical education (CME) credits are available through IDSA and HIVMA.

George H. Karam, MD, and Arturo Casadevall, MD, PhD, FIDSA